Marc Sinatra holds a BSc (Hons, Genetics) from the University of Melbourne and an MBA from the Melbourne Business School. He is a keen observer of the biotechnology sector and formerly worked for Bio-21 as a business development manager.
Each month, Marc provides a financial analysis of the Australian biotechnology industry, focusing on a specific company’s intellectual property, stage of development, balance sheet and share price performance.
Each company report is a detailed snapshot of the financial state of the enterprise with Marc Sinatra’s recommendation.
Marc also comments on topical issues as and when they occur in his ongoing Bioguide Brief Notes - see below.
Marc Sinatra's Bioguide Brief Notes:
Topical analyses of companies, mergers
and issues facing the sector
Contact Marc using the form below